GlassScriptPhysician profile
Robert W Orgain
NPI 1689677619
$13,112.70
in general payments reported to CMS, 2019-2025
53 companies · $1,852 in 2025
The $1,852 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,952 · 2020: $1,325 · 2021: $1,656 · 2022: $2,345 · 2023: $2,113 · 2024: $1,869 · 2025: $1,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,740 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,740.23 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,666.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,014.32 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $923.39 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $907.60 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $837.35 | 2020-2025 | |
| Astellas Pharma US INC | $796.21 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $782.25 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $707.56 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $509.55 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $441.68 | 2022-2025 | |
| Allergan, INC. | $265.54 | 2019-2020 | |
| Daiichi Sankyo INC. | $262.10 | 2019-2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $242.44 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $238.87 | 2019-2023 | |
| Abbott Laboratories | $235.43 | 2022-2025 | Freestyle Libre 3 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Orgain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.